Skip to main content
main-content

Insulin

News

16-07-2019 | Insulin | News

Early hypoglycemia common after starting basal insulin therapy

Almost one in 10 people with type 2 diabetes who begin basal insulin therapy through the Medicare health program experience hypoglycemia within 6 months, US research suggests.

15-07-2019 | Medications | News

Second-line type 2 diabetes therapies vary globally

Second-line therapy choices for people with type 2 diabetes vary widely throughout the world and are influenced not only by clinical characteristics but also non-medical factors such as affordability and availability, results from the DISCOVER study show.

11-07-2019 | Insulin glargine | News

Support for Gla-300 use in older people with type 2 diabetes

Older type 2 diabetes patients receiving basal insulin treatment who switch to glargine 300 units/mL experience greater or similar improvements in glycemic control compared with those switching to a first-generation basal insulin, with lower hypoglycemia risk, researchers report.

Read more

Opinion

30-05-2018 | Insulin | Editorial | Article

Hit early, hit hard: The EADSG insulin guidelines

Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles.

16-05-2018 | Devices and technology | Editorial | Article

Digital diabetology

Editorial Board member Sanjay Kalra presents his view on the march toward greater integration of digital health technologies and how traditional approaches to diabetes management are already changing.

02-05-2018 | Insulin | Editorial | Article

Glycemic goal setting in type 1 diabetes: Time to get SMART in the clinic?

Diabetes and endocrinology Consultant and Advisory Board member Terence Pang highlights the benefits that a structured approach to glycemic goal setting can bring to your practice and patients with type 1 diabetes.

In depth

19-02-2019 | Artificial pancreas systems | Feature | Article

What’s all the fuss about the DIY artificial pancreas?

DIY closed-loop insulin delivery has provoked controversy within the diabetes community, raising questions around patient empowerment, safety and liability, and whether the regulatory process remains fit for purpose in a technological age. medwireNews takes a look at the issues.

30-09-2018 | UKPDS | Feature | Article

The UKPDS: A lasting legacy

Twenty years after the publication of the primary findings, medwireNews talks to longtime UKPDS investigator Professor David Matthews (University of Oxford, UK) about the struggles of the team to bring the trial to completion and the impact of the findings on diabetes care.

Journal articles and book chapters

03-11-2018 | Premixed insulins | Review | Article

Expert opinion: Patient selection for premixed insulin formulations in diabetes care

Kalra S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0521-2

04-10-2018 | Mobile technology | Review | Article

App-based insulin calculators: Current and future state

Eiland L et al. Curr Diab Rep 2018; 18: 123. doi: 10.1007/s11892-018-1097-y

18-08-2018 | Continuous glucose monitoring | Review | Article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

In practice

01-06-2017 | Type 2 diabetes | Review | Article

Practical recommendations for transitioning patients with type 2 diabetes from hospital to home

Donihi AC. Curr Diab Rep 2017; 17: 52. doi: 10.1007/s11892-017-0876-1

Case reports

Image Credits